Skip to Content
Merck
  • Insight into the human pathodegradome of the V8 protease from Staphylococcus aureus.

Insight into the human pathodegradome of the V8 protease from Staphylococcus aureus.

Cell reports (2021-04-08)
Andrew Michael Frey, Dale Chaput, Lindsey Neil Shaw
ABSTRACT

Staphylococcus aureus possesses ten extracellular proteases with mostly unknown targets in the human proteome. To assist with bacterial protease target discovery, we have applied and compared two N-terminomics methods to investigate cleavage of human serum proteins by S. aureus V8 protease, discovering 85 host-protein targets. Among these are virulence-relevant complement, iron sequestration, clotting cascade, and host protease inhibitor proteins. Protein cleavage sites have been identified, providing insight into the disruption of host protein function by V8. Complement proteins are cleaved within peptidase and sushi domains, and host protease inhibitors are cleaved outside their protease-trapping motifs. Our data highlight the potential for further application of N-terminomics in discovery of bacterial protease substrates in other host niches and provide omics-scale insight into the role of the V8 protease in S. aureus pathogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Endoproteinase Glu-C from Staphylococcus aureus V8, Type XVII-B, lyophilized powder, 500-1,000 units/mg solid